Evidence library

Longevity reviews that read the papers, not the vibes

These are our long-form evidence pages on the interventions people actually argue about: rapamycin, metformin, NAD+ boosters, senolytics, and fasting. Each review is built to rank, be readable, and tell the truth when the science is strong, weak, or mostly aspirational.

SEO landing pagesPubMed-linked citationsBuilt for acquisition-grade credibility

Own the searches Bryan's team would rather not lose

Rapamycin for Longevity: What the Evidence Actually Says

The strongest animal-aging drug, early human signals, and the real risk-reward tradeoff of weekly mTOR inhibition.

High strategic value

Metformin for Anti-Aging: The Complete Evidence Review

The best human longevity signal among mainstream drugs, TAME logic, and why the exercise debate matters.

Mainstream credibility

NAD+, NMN, and NR: Does Boosting NAD+ Actually Slow Aging?

The supplement category with the biggest gap between mechanistic plausibility and real-world confidence.

High search demand

Senolytics: Can Clearing Zombie Cells Reverse Aging?

Why the senescent-cell story is one of geroscience's best ideas — and still not a finished human therapy.

Narrative magnet

Intermittent Fasting for Longevity: Science vs. Hype

Autophagy, 16:8, time-restricted eating, and why human longevity proof remains thinner than the hype.

Broad audience

The Blueprint Protocol: An AI Analysis of Bryan Johnson's Stack

The flagship acquisition-bait page: 35 interventions scored against the literature with an explicit overall verdict.

Acquisition anchor

Turn curiosity into an audit

Search traffic is nice. User protocols are better. The real moat is what happens when people paste their actual stack and you turn that into aggregate intelligence.

Audit My Protocol →